Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis

International Journal of Clinical Practice

Volumn 67, Issue 7, 2013, Pages 656-664

  Dini, F L ^a   Ghio, S ^b   Klersy, C ^b   Rossi, A ^c   Simioniuc, A ^a   Scelsi, L ^b   Genta, F T ^d   Cicoira, M ^c   Tavazzi, L ^e   Temporelli, P L ^d  

^a UNIVERSITY OF PISA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d IRCCS   (Italy)

^e Fondazione ES per la Ricerca Scientifica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROPENSITY SCORE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; FUROSEMIDE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPENSITY SCORE; RENAL INSUFFICIENCY, CHRONIC; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; SULFONAMIDES; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 84879089221     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12144     Document Type: Article

References (25)

1. McMurray JJ, Adamopoulos S, Anker SD, et al.; ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33: 1787-847.
2. Yilmaz MB, Gayat E, Salem R, et al. Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis. Eur J Heart Fail 2011; 13: 1244-52.
3. Felker GM, Lee KL, Bull DA, et al.; NHLBI Heart Failure Clinical Research Network. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011; 364: 797-805.
4. de Silva R, Nikitin NP, Witte KK, et al. Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. Eur Heart J 2006; 27: 569-81.
5. Harjai KJ, Dinshaw HK, Nunez E, et al. The prognostic implications of outpatient diuretic dose in heart failure. Int J Cardiol 1999; 71: 219-25.
6. Neuberg GW, Miller AB, O'Connor CM, et al.; PRAISE Investigators. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J 2002; 144: 31-8.
7. Domanski M, Norman J, Pitt B, Haigney M, Hanlon S, Peyster E,. Diuretic use, progressive heart failure, and death in patients in the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 2003; 42: 705-8.
8. Eshaghian S, Horwich TB, Fonarow GC,. Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol 2006; 97: 1759-64.
9. Ahmed A, Husain A, Love TE, et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 2006; 27: 1431-9.
10. Abdel-Qadir HM, Tu JV, Yun L, Austin PC, Newton GE, Lee DS,. Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization. Am Heart J 2010; 160: 264-71.
11. Smilde TD, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL,. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation 2006; 114: 1572-80.
12. Giannuzzi P, Temporelli PL, Bosimini E, et al. Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. J Am Coll Cardiol 1996; 28: 383-90.
13. Temporelli P, Scapellato F, Corrà U, Eleuteri E, Imparato A, Giannuzzi P,. Estimation of pulmonary wedge pressure by transmitral Doppler in patients with chronic heart failure and atrial fibrillation. Am J Cardiol 1999; 83: 724-7.
14. Nishimura RA, Tajik AJ,. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol 1997; 30: 8-18.
15. The MeRGE Heart Failure Collaborators. Independence of restrictive filling pattern and LV ejection fraction with mortality in heart failure: An individual patient meta-analysis. Eur J Heart Fail 2008; 10: 786-92.
16. Heinze G, Juni P,. An overview of the objectives of and the approaches to propensity score analyses. Eur Heart J 2011; 32: 1704-8.
17. Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P,. Untreated heart-failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 1987; 57: 17-22.
18. Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN,. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart-failure: activation of the neurohumoral axis. Ann Intern Med 1985; 103: 1-6.
19. Butler J, Forman DE, Abraham WT, et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 2004; 147: 331-8.
20. Faris R, Flather M, Purcell H, Henein MY, Poole-Wilson P, Coats A,. Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. Int J Cardiol 2002; 82: 149-58.
21. Volz EM, Felker GM,. How to use diuretics in heart failure. Curr Treat Options Cardiovasc Med 2009; 11: 426-32.
22. McCurley JM, Hanlon SU, Wei SK, Wedam EF, Michalski M, Haigney MC,. Furosemide and the progression of left ventricular dysfunction in experimental heart failure. J Am Coll Cardiol 2004; 44: 1301-7.
23. Cooper HA, Dries DL, Davis CE, Shen YL, Domanski MJ,. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 1999; 100: 1311-5.
24. Gupta S, Waywell C, Gandhi N, et al. The effects of adding torasemide to standard therapy on peak oxygen consumption, natriuretic peptides and quality of life in patients with compensated left ventricular systolic dysfunction. Eur J Heart Fail 2010; 12: 746-52.
25. Grinstead WC, Francis MJ, Marks GF, Tawa CB, Zoghbi WA, Young JB,. Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy. Am J Cardiol 1994; 73: 881-6.